Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.49% | -11.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.49% | -11.17% | |||
| Cost of Revenue | 1.68% | -3.78% | |||
| Gross Profit | -33.17% | -19.23% | |||
| SG&A Expenses | 5.52% | -3.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.73% | -4.58% | |||
| Operating Income | -78.27% | -40.58% | |||
| Income Before Tax | 73.52% | -937.66% | |||
| Income Tax Expenses | -102.25% | 112.77% | |||
| Earnings from Continuing Operations | 73.58% | -1,114.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -73.54% | 1,013.61% | |||
| Net Income | 73.60% | -1,205.71% | |||
| EBIT | -78.27% | -40.58% | |||
| EBITDA | -363.61% | -282.15% | |||
| EPS Basic | 73.64% | -1,153.76% | |||
| Normalized Basic EPS | -99.49% | 1,474.54% | |||
| EPS Diluted | 73.66% | -1,154.48% | |||
| Normalized Diluted EPS | -99.49% | 1,474.54% | |||
| Average Basic Shares Outstanding | 0.18% | 4.21% | |||
| Average Diluted Shares Outstanding | 0.18% | 4.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||